Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:2372-2378
Published online before print September 30, 2002, doi: 10.1161/01.CIR.0000033972.90653.AF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/18/2372    most recent
01.CIR.0000033972.90653.AFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Circulation. 2002;106:2372.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Plasminogen Activator Inhibitor-1 Promotes Formation of Endothelial Microparticles With Procoagulant Potential

Sergey V. Brodsky, MD, PhD; Kazimierz Malinowski, PhD; Marc Golightly, MD; Jolyon Jesty, PhD; Michael S. Goligorsky, MD, PhD

From the Department of Medicine (S.V.B., M.S.G.), New York Medical College, Valhalla, NY, and Departments of Surgery (K.M.), Pathology (M.G.), and Medicine (J.J.), State University of New York, Stony Brook, NY.

*Correspondence to Michael S. Goligorsky, MD, PhD, Department of Medicine/Nephrology, Basic Sciences Building, Room C-23, New York Medical College, Valhalla, NY 11595. E-mail michael_goligorsky{at}nymc.edu

Background— Endothelial dysfunction is emerging as a common denominator for diverse and highly prevalent cardiovascular diseases. Increased level of plasminogen activator inhibitor-1 (PAI-1) and procoagulant activity have been recognized as hallmarks of endothelial dysfunction. This study was aimed at investigating cellular actions of PAI-1 and a potential link between PAI-1 and procoagulant state.

Methods and Results— Human umbilical vein endothelial cells treated with PAI-1 were subjected to laser confocal fluorescence microscopy, immunoprecipitation and Western blotting, and FACS analysis for isolation and identification of endothelial microparticles. PAI-1 treatment resulted in a reduced expression of uPAR, its colocalization with caveolin, and the concomitant increase of uPAR abundance in the culture medium. FACS analysis revealed that PAI-1 rapidly and dose-dependently increased the number of endothelial microparticles expressing uPAR and {alpha}Vß3 integrin. This process was attenuated by pretreatment with neutralizing anti-uPAR antibodies. PAI-1 knockout mice showed a significantly decreased number of circulating endothelial microparticles than wild-type mice; however, PAI-1–deficient animals responded to infusion of PAI-1 with a more pronounced rise in the number of microparticles. PAI-1 treatment increased the number of microparticles stained with Annexin V, evidence for the expression of anionic phospholipids. This was accompanied by the accelerated generation of thrombin.

Conclusions— The data disclose a novel effect of PAI-1 to dose-dependently promote formation of endothelial microparticles with the reduced transmembrane asymmetry of phospholipids. This phenomenon may be responsible for the observed increase in in vitro thrombin generation. These findings could potentially link these hallmarks of endothelial dysfunction—elevated levels of PAI-1 and propensity toward thrombosis.


Key Words: endothelium • urokinase • thrombosis




This article has been cited by other articles:


Home page
BloodHome page
R. Lacroix, F. Sabatier, A. Mialhe, A. Basire, R. Pannell, H. Borghi, S. Robert, E. Lamy, L. Plawinski, L. Camoin-Jau, et al.
Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro
Blood, October 1, 2007; 110(7): 2432 - 2439.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Zhao and G. X. Shen
Involvement of Heat Shock Factor-1 in Glycated LDL-Induced Upregulation of Plasminogen Activator Inhibitor-1 in Vascular Endothelial Cells
Diabetes, May 1, 2007; 56(5): 1436 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2594 - 2604.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Sapet, S. Simoncini, B. Loriod, D. Puthier, J. Sampol, C. Nguyen, F. Dignat-George, and F. Anfosso
Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2
Blood, September 15, 2006; 108(6): 1868 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Werner, S. Wassmann, P. Ahlers, S. Kosiol, and G. Nickenig
Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 112 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Mezentsev, R. M. H. Merks, E. O'Riordan, J. Chen, N. Mendelev, M. S. Goligorsky, and S. V. Brodsky
Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1106 - H1114.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Al-Nedawi, J. Szemraj, and C. S. Cierniewski
Mast Cell-Derived Exosomes Activate Endothelial Cells to Secrete Plasminogen Activator Inhibitor Type 1
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1744 - 1749.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Perez-Casal, C. Downey, K. Fukudome, G. Marx, and C. H. Toh
Activated protein C induces the release of microparticle-associated endothelial protein C receptor
Blood, February 15, 2005; 105(4): 1515 - 1522.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. C. Ferreira, A. A. Peter, A. J. Mendez, J. J. Jimenez, L. M. Mauro, J. A. Chirinos, R. Ghany, S. Virani, S. Garcia, L. L. Horstman, et al.
Postprandial Hypertriglyceridemia Increases Circulating Levels of Endothelial Cell Microparticles
Circulation, December 7, 2004; 110(23): 3599 - 3603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. V. Brodsky, F. Zhang, A. Nasjletti, and M. S. Goligorsky
Endothelium-derived microparticles impair endothelial function in vitro
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1910 - H1915.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. V. Brodsky, O. Gealekman, J. Chen, F. Zhang, N. Togashi, M. Crabtree, S. S. Gross, A. Nasjletti, and M. S. Goligorsky
Prevention and Reversal of Premature Endothelial Cell Senescence and Vasculopathy in Obesity-Induced Diabetes by Ebselen
Circ. Res., February 20, 2004; 94(3): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp
Infections and endothelial cells
Cardiovasc Res, October 15, 2003; 60(1): 40 - 48.
[Abstract] [Full Text] [PDF]